BEAM
Price
$18.79
Change
+$2.48 (+15.21%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
1.9B
67 days until earnings call
PLUR
Price
$5.15
Change
+$0.20 (+4.04%)
Updated
Sep 3 closing price
Capitalization
40.54M
Interact to see
Advertisement

BEAM vs PLUR

Header iconBEAM vs PLUR Comparison
Open Charts BEAM vs PLURBanner chart's image
Beam Therapeutics
Price$18.79
Change+$2.48 (+15.21%)
Volume$212.57K
Capitalization1.9B
Pluri
Price$5.15
Change+$0.20 (+4.04%)
Volume$1.54K
Capitalization40.54M
BEAM vs PLUR Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PLUR commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and PLUR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (BEAM: $16.31 vs. PLUR: $4.95)
Brand notoriety: BEAM and PLUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 70% vs. PLUR: 12%
Market capitalization -- BEAM: $1.9B vs. PLUR: $40.54M
BEAM [@Biotechnology] is valued at $1.9B. PLUR’s [@Biotechnology] market capitalization is $40.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePLUR’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PLUR’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PLUR’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • PLUR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than PLUR.

Price Growth

BEAM (@Biotechnology) experienced а -1.98% price change this week, while PLUR (@Biotechnology) price change was -4.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.9B) has a higher market cap than PLUR($40.5M). PLUR YTD gains are higher at: 15.815 vs. BEAM (-34.234). PLUR has higher annual earnings (EBITDA): -20.22M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. PLUR (26.3M). PLUR has less debt than BEAM: PLUR (31.2M) vs BEAM (155M). BEAM has higher revenues than PLUR: BEAM (60.3M) vs PLUR (1.03M).
BEAMPLURBEAM / PLUR
Capitalization1.9B40.5M4,686%
EBITDA-414.33M-20.22M2,049%
Gain YTD-34.23415.815-216%
P/E RatioN/AN/A-
Revenue60.3M1.03M5,832%
Total Cash1.15B26.3M4,373%
Total Debt155M31.2M497%
FUNDAMENTALS RATINGS
PLUR: Fundamental Ratings
PLUR
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPLUR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPGAX21.55N/A
N/A
Fidelity Advisor Equity Growth A
IRVAX25.46-0.09
-0.35%
Voya Russell Large Cap Value Idx Port A
JDDVX12.86-0.09
-0.69%
Janus Henderson U.S. Dividend Income D
TGSAX10.08-0.11
-1.08%
Templeton Global Smaller Comp Adv
BCSFX26.59-0.70
-2.57%
Brown Capital Mgmt Intl Sm Co Instl

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.31%
CRSP - BEAM
67%
Closely correlated
+1.60%
NTLA - BEAM
64%
Loosely correlated
+0.40%
RXRX - BEAM
63%
Loosely correlated
-0.85%
SYRE - BEAM
58%
Loosely correlated
+0.85%
DNLI - BEAM
56%
Loosely correlated
+1.18%
More

PLUR and

Correlation & Price change

A.I.dvisor tells us that PLUR and RZLT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLUR and RZLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
-6.05%
RZLT - PLUR
29%
Poorly correlated
+0.70%
BNTX - PLUR
28%
Poorly correlated
+0.62%
RLMD - PLUR
27%
Poorly correlated
+26.79%
BEAM - PLUR
26%
Poorly correlated
-0.31%
STRO - PLUR
26%
Poorly correlated
+10.96%
More